McCormick & -MD Earnings Calls
| Release date | Jun 25, 2026 |
| EPS estimate | $0.692 |
| EPS actual | $0.80 |
| EPS Surprise | 15.61% |
| Revenue estimate | 1.914B |
| Revenue actual | 1.937B |
| Revenue Surprise | 1.20% |
| Release date | Mar 31, 2026 |
| EPS estimate | $0.594 |
| EPS actual | $0.660 |
| EPS Surprise | 11.11% |
| Revenue estimate | 1.787B |
| Revenue actual | 1.874B |
| Revenue Surprise | 4.89% |
| Release date | Jan 22, 2026 |
| EPS estimate | $0.88 |
| EPS actual | $0.86 |
| EPS Surprise | -1.83% |
| Revenue estimate | 1.845B |
| Revenue actual | 1.85B |
| Revenue Surprise | 0.307% |
| Release date | Oct 07, 2025 |
| EPS estimate | $0.83 |
| EPS actual | $0.84 |
| EPS Surprise | 0.97% |
| Revenue estimate | 1.715B |
| Revenue actual | 1.725B |
| Revenue Surprise | 0.561% |
Last 4 Quarters for McCormick & -MD
Below you can see how MKC-V performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 07, 2025 |
| Price on release | $65.84 |
| EPS estimate | $0.83 |
| EPS actual | $0.84 |
| EPS surprise | 0.97% |
| Date | Price |
|---|---|
| Oct 01, 2025 | $67.70 |
| Oct 02, 2025 | $67.80 |
| Oct 03, 2025 | $68.62 |
| Oct 06, 2025 | $68.17 |
| Oct 07, 2025 | $65.84 |
| Oct 08, 2025 | $66.03 |
| Oct 09, 2025 | $65.79 |
| Oct 10, 2025 | $66.65 |
| Oct 13, 2025 | $65.25 |
| 4 days before | -2.75% |
| 4 days after | -0.90% |
| On release day | 0.289% |
| Change in period | -3.62% |
| Release date | Jan 22, 2026 |
| Price on release | $61.72 |
| EPS estimate | $0.88 |
| EPS actual | $0.86 |
| EPS surprise | -1.83% |
| Date | Price |
|---|---|
| Jan 15, 2026 | $68.25 |
| Jan 16, 2026 | $67.03 |
| Jan 20, 2026 | $67.46 |
| Jan 21, 2026 | $66.30 |
| Jan 22, 2026 | $61.72 |
| Jan 23, 2026 | $60.45 |
| Jan 26, 2026 | $60.45 |
| Jan 27, 2026 | $63.58 |
| Jan 28, 2026 | $61.73 |
| 4 days before | -9.57% |
| 4 days after | 0.0222% |
| On release day | -2.06% |
| Change in period | -9.55% |
| Release date | Mar 31, 2026 |
| Price on release | $50.42 |
| EPS estimate | $0.594 |
| EPS actual | $0.660 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $52.57 |
| Mar 26, 2026 | $51.85 |
| Mar 27, 2026 | $52.97 |
| Mar 30, 2026 | $53.63 |
| Mar 31, 2026 | $50.42 |
| Apr 01, 2026 | $48.37 |
| Apr 02, 2026 | $49.18 |
| Apr 06, 2026 | $51.10 |
| Apr 07, 2026 | $51.41 |
| 4 days before | -4.09% |
| 4 days after | 1.96% |
| On release day | -4.07% |
| Change in period | -2.21% |
| Release date | Jun 25, 2026 |
| Price on release | $48.87 |
| EPS estimate | $0.692 |
| EPS actual | $0.80 |
| EPS surprise | 15.61% |
| Date | Price |
|---|---|
| Jun 18, 2026 | $46.51 |
| Jun 22, 2026 | $45.70 |
| Jun 23, 2026 | $47.18 |
| Jun 24, 2026 | $47.45 |
| Jun 25, 2026 | $48.87 |
| Jun 26, 2026 | $50.88 |
| Jun 29, 2026 | $51.43 |
| Jun 30, 2026 | $50.71 |
| Jul 01, 2026 | $51.78 |
| 4 days before | 5.07% |
| 4 days after | 5.95% |
| On release day | 4.12% |
| Change in period | 11.33% |
McCormick & -MD Earnings Call Transcript Summary of Q2 2026
McCormick reported strong second-quarter results driven by the McCormick de Mexico acquisition and robust momentum in Flavor Solutions. Total sales rose 14% CC, with organic growth of 2% (driven by pricing) and a 12% contribution from the Mexico acquisition. Flavor Solutions delivered above‑expectation volume growth across large CPG, private label and high‑growth innovators, and branded food service improved with better foot traffic and e‑commerce. Consumer volumes were pressured in the Americas (notably U.S. spices & seasonings) by increased price sensitivity and private‑label competition; management expects sequential volume improvement in Q3 and volume growth in Q4 via targeted revenue management, expanded distribution, renovation, and increased brand/precision marketing. Gross profit margin expanded ~270 bps (underlying +130 bps) aided by a $28M tariff refund, acquisition accretion, surgical pricing, and CCI savings; full‑year gross margin is guided to expand 100–120 bps. Adjusted EPS was $0.80 (+16% YoY), with the tariff refund contributing ~$0.07/sh. Cash flow from ops for H1 was $431M; leverage was ~2.9x and management expects to continue delevering pre‑ and post‑Unilever Foods close. Integration planning with Unilever Foods is well advanced; company reiterates confidence in previously announced synergy and accretion targets (mid‑high single‑digit adjusted EPS accretion in year 1, mid‑high teens in year 3). Risks include persistent inflationary pressures (Middle East conflict, fuel), consumer move to value, and QSR softness in some regions. Q3 operating income is expected to grow high single digits to low double digits (SG&A phasing, ERP and brand spend), and full‑year outlook remains broadly consistent with prior guidance.
Sign In
Buy MKC-V